Gainers
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) surged 95.3% to close at $0.2580 on Thursday after Ladenburg Thalmann initiated coverage on the stock with a Buy rating and announced a price target of $6.50.
Top Biden administration officials are poised to lay out new steps to accelerate the U.S. response amid the spread of monkeypox and demand for vaccines & treatments.
Software-as-a-services (SAAS) and cloud intelligent systems provider WeTrade Group Inc (NASDAQ:WETG) is in an advanced discussion with Zhixun Biotechnology Limited to launch an in-depth…
WeTrade Group Inc (NASDAQ: WETG) collaborated with MobiLab Medical Innovatives to launch a globally unparalleled and one-of-a-kind Monkeypox Virus testing kit with…